NWI Management »

Cogent Biosciences shares owned by NWI Management

Quarter-by-quarter ownership of Cogent Biosciences (COGT) shares owned by NWI Management from 13F filings

Historical chart of NWI Management investment in Cogent Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cogent Biosciences held by NWI Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cogent Biosciences by NWI Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $8.6M 242k 35.52

More positions owned by NWI Management

Eli Lilly & Co. (LLY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Natera Call Option (NTRA)
Insmed Com Par $.01 (INSM)
Microsoft Corporation Call Option (MSFT)
Nu Hldgs Ord Shs Cl A Call Option (NU)
MercadoLibre Call Option (MELI)
Amazon Call Option (AMZN)
Dbx Etf Tr Xtrack Hrvst Csi Call Option (ASHR)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Freeport-mcmoran CL B Call Option (FCX)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Intercorp Finl Svcs SHS (IFS)
Micron Technology (MU)

View all positions for NWI Management

Top funds holding Cogent Biosciences

FMR
BlackRock
Vanguard Group
Deerfield Management Company
Fairmount Funds Management
Rtw Investments
Kynam Capital Management
TCG Crossover Management
State Street Corporation
Geode Capital Management
Henderson Group
Balyasny Asset Management
Vivo Capital
Octagon Capital Advisors
Duquesne Family Office

View all funds holding Cogent Biosciences